Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 7Completed 4Unknown 2Terminated 2Suspended 1Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 9NET 1Lymphoid 1Endocrine 1Classical hematology 1Breast 1

Conditions

Neuroendocrine Tumors 5Carcinoma, Neuroendocrine 2Breast Neoplasms 2Sarcoma 1Prostatic Neoplasms 1Melanoma 1Lymphoma 1Gastro-enteropancreatic neuroendocrine tumor 1Disease Progression 1Carcinoma 1Carcinoid Tumor 1Adenoma, Islet Cell 1Adenocarcinoma 1

Interventions

Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Sarcoma × NET × Clear all
NCT05396118 2024-05-14

Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients

Rigshospitalet, Denmark

Phase 2 Enrolling by invitation
15 enrolled
BreastEndocrineLymphoidNETSarcoma

Breast Neoplasms, Lymphoma, Sarcoma, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡